PD-046 Phase II randomized trial adding a toll-like...

Lung Cancer 2005 / 7 Vol. 49

PD-046 Phase II randomized trial adding a toll-like receptor 9 agonist (ProMuneTM) to first line chemotherapy shows improved response in advanced non-small cell lung cancer

Manegold, C., Leichman, G., Gravenor, D., Woytowitz, D., Mezger, J., Haarmann, C., Al-Adhami, M., Schmalbach, T., Whisnant, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80379-4
Date:
July, 2005
File:
PDF, 273 KB
english, 2005
Conversion to is in progress
Conversion to is failed